Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units

Antibiotiki i Khimioterapiya

Volumn 56, Issue 5-6, 2011, Pages 37-45

  Bogomolova, N S ^a   Bolshakov, L V ^a   Kuznetsova, S M ^a   Oreshkina, T D ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Antibiotic susceptibility; Enterococci; Isolation; Staphylococci; Surgical infections

Indexed keywords

ACETAMIDE DERIVATIVE; AMOXICILLIN; ANTIINFECTIVE AGENT; CEFOXITIN; FUSIDIC ACID; LINEZOLID; OXACILLIN; OXAZOLIDINONE DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; GRAM POSITIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; PLASTIC SURGERY; RUSSIAN FEDERATION;

ACETAMIDES; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CEFOXITIN; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FLUOROQUINOLONES; FUSIDIC ACID; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOSCOW; OXACILLIN; OXAZOLIDINONES; RIFAMPIN; SURGERY, PLASTIC; VANCOMYCIN;

ENTEROCOCCUS FAECALIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 81755168946     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Vincent J. I., Bihar! D. J., Sitter P. M. et al. The prevalence of nosocomial infection care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study/ EPIC International Advisory Committee. JAMA 1995; 274:639-644.
2. Albert C, Brun-BuissonC, Burchardi H. et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Inten Care Vtd 2002; 28:108-121. (Pubitemid 34293822)
3. Dekhnich A. V. et al. Succeptibility of Staphylococcus aureus nosocomial isolates in Russia: five-year trends. Clin Microbiol Infect 2009; 15: 1076.
4. Geffers C, Zuschneid I., Sohr D. et al. Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections Surveillance System (KISS). Anesthesiol Intensivmed Notfallmed Schmerzther2004; 39:1:15-9.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: twelfth informacional supplement. CLSI Document Ml00-S4.2008; 22:1.
6. Vincent J. I. EPIC II: sepsis around the world. Minerva Anesthesiol 2008; 74: 6: 293-296.
7. Ogrady N. P. et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002; 51 (RR-10): 1-29.
8. NNIS System report. Data summary from January 1990-1999, issued June 1999. AM J Infect Control 1999; 27:6:520-532.
9. Shurland S. et al. Comparison of mortality risk associated with bacteriemia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemol 2007; 28: 3: 273-279. (Pubitemid 46480725)
10. Eliopoulus G. E. Enterococcal endocarditis. In: Kaye D.,ed. Infective Endocarditis. 2nd ed. N.Y.: Raven Press. 1992; 209-223.